Holdings

Jones Hill Capital LP

As of Sep 30, 2026, Jones Hill Capital LP reported 31 positions worth US$558M. Largest: BioMarin Pharmaceutical Inc., BioCryst Pharmaceuticals, Inc. and Travere Therapeutics, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
BioMarin Pharmaceutical Inc.1.17MUS$70.3M−260KSep 30, 2026
BioCryst Pharmaceuticals, Inc.7.08MUS$59MnewSep 30, 2026
Travere Therapeutics, Inc.960KUS$56.5MnewSep 30, 2026
Indivior Pharmaceuticals, Inc.1.53MUS$54.7MnewSep 30, 2026
Celcuity Inc.383KUS$30.4MnewSep 30, 2026
Ionis Pharmaceuticals, Inc.600KUS$26.8MnewSep 30, 2026
Supernus Pharmaceuticals, Inc.602KUS$25.9MnewSep 30, 2026
Nuvation Bio Inc.4.49MUS$25.1MnewSep 30, 2026
Vera Therapeutics, Inc.652KUS$21.1MnewSep 30, 2026
Trevi Therapeutics, Inc.1.45MUS$20.7M+108KSep 30, 2026